CA2557181A1 - Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de facon differentielle dans les cellules musculaires - Google Patents

Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de facon differentielle dans les cellules musculaires Download PDF

Info

Publication number
CA2557181A1
CA2557181A1 CA002557181A CA2557181A CA2557181A1 CA 2557181 A1 CA2557181 A1 CA 2557181A1 CA 002557181 A CA002557181 A CA 002557181A CA 2557181 A CA2557181 A CA 2557181A CA 2557181 A1 CA2557181 A1 CA 2557181A1
Authority
CA
Canada
Prior art keywords
protein
human
mouse
gene
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002557181A
Other languages
English (en)
Inventor
John J. Kopchick
Karen T. Coschigano
Keith S. Boyce
Andres Kriete
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio University
Cogenics Icoria Inc
Original Assignee
Ohio University
Icoria, Inc.
John J. Kopchick
Karen T. Coschigano
Keith S. Boyce
Andres Kriete
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio University, Icoria, Inc., John J. Kopchick, Karen T. Coschigano, Keith S. Boyce, Andres Kriete filed Critical Ohio University
Publication of CA2557181A1 publication Critical patent/CA2557181A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002557181A 2004-02-26 2005-02-24 Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de facon differentielle dans les cellules musculaires Abandoned CA2557181A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54751204P 2004-02-26 2004-02-26
US60/547,512 2004-02-26
US57934204P 2004-06-15 2004-06-15
US60/579,342 2004-06-15
PCT/US2005/005596 WO2005082398A2 (fr) 2004-02-26 2005-02-24 Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de façon differentielle dans les cellules musculaires

Publications (1)

Publication Number Publication Date
CA2557181A1 true CA2557181A1 (fr) 2005-09-09

Family

ID=34915602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002557181A Abandoned CA2557181A1 (fr) 2004-02-26 2005-02-24 Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de facon differentielle dans les cellules musculaires

Country Status (4)

Country Link
EP (1) EP1732582A2 (fr)
AU (1) AU2005216922A1 (fr)
CA (1) CA2557181A1 (fr)
WO (1) WO2005082398A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
CA2587790A1 (fr) * 2004-12-07 2006-06-15 Ohio University Diagnostic de l'hyperinsulinemie et du diabete de type ii et protection contre ceux-ci sur la base de proteines exprimees differemment dans le serum
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
CN102333889A (zh) * 2009-02-27 2012-01-25 韦尔瓦制药有限公司 基于基因表达特征的ⅱ型糖尿病的药物鉴别方案
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2370134A1 (fr) * 1999-05-05 2000-11-09 Ohio University Genes et proteines hepatiques pouvant etre regules par l'hormone de croissance, utilisations associees
WO2004092419A2 (fr) * 2003-03-31 2004-10-28 Ohio University Diagnosis de l'hyperinsulinemie et du diabette de type ii et protection correspondante (i)

Also Published As

Publication number Publication date
AU2005216922A1 (en) 2005-09-09
WO2005082398A2 (fr) 2005-09-09
EP1732582A2 (fr) 2006-12-20
WO2005082398A3 (fr) 2006-01-26

Similar Documents

Publication Publication Date Title
US8022189B2 (en) Isolated antibodies against biologically active leptin-related peptides
CA2557181A1 (fr) Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de facon differentielle dans les cellules musculaires
CA2527957A1 (fr) Procedes de diagnostic et de traitement lies au vieillissement, en particulier au vieillissement du foie
WO2006023121A1 (fr) Diagnostic d'hyperinsulinemie et de diabete de type ii et protection contre ceux-ci a base de genes differentiellement exprimes dans le tissu adipeux blanc (13)
CN106030311A (zh) 线粒体融合蛋白的方法和用途
WO2000023100A2 (fr) Genes et proteines destines a la prevention et therapie de maladies renales et de troubles associes
US20070142311A1 (en) Diagnosis of hyperinsulinemia and type II diabetes and protection against same
WO2005110460A2 (fr) Méthodes de traitement et diagnostics relatifs au vieillissement, particulièrement celui des muscles (14.1)
WO2005046718A1 (fr) Diagnostic de l'hyperinsulinemie et du diabete de type ii et protection contre ces maladies sur la base de genes d'expression differentielle dans des cellules pancreatiques (12.1)
KR20120061070A (ko) 당뇨병 치료를 위한 ｍｇ２９를 조정하는 조성물 및 방법
EP2619330B1 (fr) Procédés pour identifier des composés permettant d'augmenter l'expression ou l'activité de l'aspartyl aminopeptidase
WO2004092419A2 (fr) Diagnosis de l'hyperinsulinemie et du diabette de type ii et protection correspondante (i)
US20060240500A1 (en) Diagnosis of kidney damage and protection against same
EP1649063A2 (fr) Methodes de diagnostic et de traitement se rapportant au vieillissement (8a)
TWI250209B (en) A novel G protein-coupled receptor, GAVE8
US20050142561A1 (en) Intracellular signaling pathways in diabetic subjects
US20030119024A1 (en) Genes and proteins associated with T cell activation
HU230404B1 (hu) Hígításon alapuló gátlóhatást mérő módszer

Legal Events

Date Code Title Description
FZDE Discontinued